(RTTNews) - Assembly Biosciences, Inc. (ASMB), a biotechnology company, Thursday announced encouraging interim data from Phase 1b study of ABI-4334 in participants with chronic hepatitis B virus ...
H.C. Wainwright notes that Assembly Biosciences (ASMB) announced an interim safety, pharmacokinetics and efficacy dataset from an ongoing Phase 1b study of ABI-4334 in patients with chronic ...
This has brought many benefits to businesses and their customers, but it can make contact center reporting more of a challenge. It’s trickier, after all, to track agent performance, customer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback